Disparities in Mental Health Screening and Support
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
- Кому может быть актуально
- Состояния в реестре: Mental Health, Cancer. Базовые параметры: Без ограничений · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Италия
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
ALTHEA - tAckLing menTal Health Cancer Patients and Their Families: Digital Solutions for bEtter cAre Work Package 3: Disparities in Mental Health Screening and Support
Обзор
To develop and administer online surveys to cancer patients and their families across diverse regions within the EU to detect possible disparities in their access to mental health screening and psychological-cognitive support
Подробное описание
In order to detect possible disparities in the access to mental health screening and psychological-cognitive support, cancer patients and survivors will be involved. A minimum of 1000 patients will be surveyed to gather insights on their experiences with mental health screening, the support they received, and perceived barriers and facilitators in accessing mental health services. Similarly, caregivers and/or family members of cancer patients will be invited to participate in this study. At least 1000 family members and caregivers who support cancer patients will also be surveyed to understand their mental health needs and the challenges they encounter in seeking support for themselves and for patients. For these surveys, individuals at all cancer stages who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer will be invited to participate. Participants must reside in the EU, have Internet access and can use a technological device for survey participation.
Considering the pediatric population, the following inclusion criteria will be adopted:
* Pediatric cancer patients 12-17 years, responding on behalf of themselves; * caregivers of pediatric cancer patients (0-11 y), responding on behalf of their child and themselves; * caregivers of pediatric cancer patients (12+ y), responding only on behalf of themselves.
Regarding caregivers and family members, the investigators will include individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for a cancer patient in the EU. As with patients, caregivers and family members should also have access to the internet and at least one technological device.
Первичные конечные точки
- Disparities in access to mental health [Срок оценки: through study completion, an average of 1 year]
Критерии участия
Inclusion Criteria for patients:
- residence in EU
- internet access
- access to a technological device for survey participation
- individuals at all cancer stages who have been diagnosed with cancer, are currently undergoing treatment or have survived cancer
- ability to understand and the willingness to sign a written informed consent document
Inclusion Criteria for family members and caregivers:
- residence in EU
- internet access
- access to a technological device for survey participation
- individuals that are aged 18 or older who currently provide, or have provided, care, psychosocial and physical support for a cancer patient in the EU
- ability to understand and the willingness to sign a written informed consent document
Критерии исключения
- NA
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Да
Дизайн исследования
- Модель наблюдения
- Другое
Центры проведения
Италия · 1 центр
- European Institute of Oncology, Milan — Milan
Идентификаторы
NCT: NCT07691281 · UID 5350 · L2-587